Multicore processing boosts performance and energy efficiency in many coding situations. Bare-metal algorithms further ...

JACKSONVILLE, Fla., March 27, 2026 /PRNewswire/ -- BionicM USA LLC and Brooks Rehabilitation have announced a collaborative clinical research study, titled Adaptive Mobility Technology: A Comparative ...

The Pharmaceutical Research and Manufacturers of America (PhRMA) has stated that the ICH M4Q(R2) involves a significant restructuring of the quality section of the Common Technical Document (CTD), ...

While I’m making new vintage hair tutorials, here is my hair as it is Posted: March 23, 2026 | Last updated: March 23, 2026 While I’m making new vintage hair tutorials, here is my hair as it is, ...

As the chain marks 50th anniversary in Britain, Karen O’Rourke explains what makes it stand out against cut-price rivals Almost exactly 50 years after H&M opened its first British store, the doors on ...

That was the bumper sticker for mergers and acquisitions in the U.S. consumer space last year. But will that trend hold this year? But the deal market also faces a lot of uncertainty, much like the ...

I have eight years of experience covering Android, with a focus on apps, features, and platform updates. I love looking at even the minute changes in apps and software updates that most people would ...

SPOILER ALERT: The following story contains plot details from “Eyes Without a Face,” Season 4, Episode 5 of “Industry,” now streaming on HBO Max. On “Industry,” heroes are hard to come by. But in the ...

Portfolio pruning in spirits and wine, major moves in functional drinks and significant transactions in emerging markets have been among the dynamics driving the deal-making in the drinks industry ...

Johnson & Johnson’s $14.6 billion buyout of Intra-Cellular Therapies in the first month of 2025 suggested it would be a big year for high-priced transactions in the biopharma industry. But it was a ...

Let’s be clear about one thing: there’s no such thing as a crystal ball. Any forecast is only looking at the best available current data and extrapolating where things might probably be heading. The ...

LaMattina is the former president of Pfizer Global R&D and is currently a senior director at PureTech Health. In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview ...